Scientific Publications
- Technology Platforms
- Research Strategy
- Intellectual Property
- Scientific Publications
| Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice Muhs A, Hickman DT, Pihlgren M, Chuard N, Giriens V, Meerschman C, van der Auwera I, van Leuven F, Sugawara M, Weingertner MC, Bechinger B, Greferath R, Kolonko N, Nagel-Steger L, Riesner D, Brady RO, Pfeifer A, Nicolau C Proc. Natl. Acad. Sci. USA 2007, 104, 9810 |
| Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells Gatouillat G, Odot J, Balasse E, Nicolau C, Tosi PF, Hickman DT, López-Deber MP, Madoulet C. Cancer Lett. 2007, 257,165 |
| Induction of auto-antibodies to murine P-glycoprotein: consequences on drug sensitivity in MDR cancer cells and on the expression of mdr genes in organs Perrin L, Gatouillat G, Balasse E, Odot J, Nicolau C, Tosi PF, Madoulet C. Biochem. Biophys. Res. Commun. 2007, 358, 325 |
| Inhibition of multidrug resistance by immunisation with synthetic P-glycoprotein-derived peptides Pawlak-Roblin C, Tosi PF, Perrin L, Devy J, Venteo L, Albert P, Nicolau C, Madoulet C. Eur. J. Cancer 2004, 40, 606 |
| A liposome-based therapeutic vaccine against beta-amyloid plaques on the pancreas of transgenic NORBA mice Nicolau C, Greferath R, Balaban TS, Lazarte JE, Hopkins RJ. Proc. Natl. Acad. Sci. USA 2002, 99, 2332 |
| Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system Spragg DD, Alford DR, Greferath R, Larsen CE, Lee KD, Gurtner GC, Cybulsky MI, Tosi PF, Nicolau C, Gimbrone MA Jr. Proc. Natl. Acad. Sci. USA 1997, 94, 8795 |
| Immune response against the murine mdr1 protein induced by vaccination with synthetic lipopeptides in liposomes Tosi PF, Radu D, Nicolau C. Biochem. Biophys. Res. Commun. 1995, 212, 494 |
